Home
TECH
TECH News

Latest Bio-Techne Corp (TECH) News on February 22, 2025

Bio-Techne Launches Expanded Menu of RNAscope Probes for Human and Mouse Transcriptome to Advance Spatial Biology

PR Newswire

2 days ago

Bio-Techne Launches Expanded Menu of RNAscope Probes for Human and Mouse Transcriptome to Advance Spatial Biology

MT Newswires

3 days ago

Baird Downgrades Bio-Techne to Neutral From Outperform, Adjusts Price Target to $68 From $88

Bio-Techne's (NASDAQ:TECH) Soft Earnings Don't Show The Whole Picture

Simply Wall St.

4 days ago

Bio-Techne's (NASDAQ:TECH) Soft Earnings Don't Show The Whole Picture

Bio-Techne Announces Release of GMP TcBuster Non-Viral Genome Engineering System

PR Newswire

4 days ago

Bio-Techne Announces Release of GMP TcBuster Non-Viral Genome Engineering System

Morningstar Research

12 days ago

Analyst Report: Bio-Techne Corporation

MT Newswires

16 days ago

Scotiabank Adjusts Bio-Techne's Price Target to $90 From $88

MT Newswires

16 days ago

KeyBanc Adjusts Bio-Techne's Price Target to $90 From $80

MT Newswires

16 days ago

Baird Adjusts Bio-Techne's Price Target to $88 From $86

MT Newswires

16 days ago

RBC Lifts Price Target on Bio-Techne to $80 From $79, Keeps Sector Perform Rating

Bio-Techne Corp (TECH) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...

GuruFocus.com

16 days ago

Bio-Techne Corp (TECH) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...

Thomson Reuters StreetEvents

16 days ago

Q2 2025 Bio-Techne Corp Earnings Call

Morningstar Research

17 days ago

Analyst Report: Bio-Techne Corporation

Bio-Techne Tops Q2 Earnings & Revenue Estimates, Stock Up in Premarket

Zacks

17 days ago

Bio-Techne Tops Q2 Earnings & Revenue Estimates, Stock Up in Premarket

MT Newswires

17 days ago

Sector Update: Health Care Stocks Lean Higher Pre-Bell Wednesday

Illumina (ILMN) Reports Earnings Tomorrow: What To Expect

StockStory

17 days ago

Illumina (ILMN) Reports Earnings Tomorrow: What To Expect

Bio-Techne (NASDAQ:TECH) Surprises With Strong Q4, Stock Soars

StockStory

17 days ago

Bio-Techne (NASDAQ:TECH) Surprises With Strong Q4, Stock Soars

MT Newswires

17 days ago

Bio-Techne's Fiscal Q2 Adjusted Earnings, Net Sales Rise

Bio-Techne Releases Second Quarter Fiscal 2025 Results

PR Newswire

17 days ago

Bio-Techne Releases Second Quarter Fiscal 2025 Results

Bio-Techne Declares Dividend

PR Newswire

17 days ago

Bio-Techne Declares Dividend

The Zacks Analyst Blog Highlights Boston Scientific, Hologic, BioTechne, STERIS and Align

Zacks

17 days ago

The Zacks Analyst Blog Highlights Boston Scientific, Hologic, BioTechne, STERIS and Align

Bio-Techne Appoints Dr. Amy E. Herr to Board of Directors

PR Newswire

18 days ago

Bio-Techne Appoints Dr. Amy E. Herr to Board of Directors

TECH Gears Up to Report Q2 Earnings: Here's What to Expect

Zacks

23 days ago

TECH Gears Up to Report Q2 Earnings: Here's What to Expect

MT Newswires

a month ago

Baird Adjusts Bio-Techne Price Target to $86 From $84, Maintains Outperform Rating

Bio-Techne to Host Conference Call on February 5, 2025, to Announce Second Quarter Fiscal 2025 Financial Results

PR Newswire

a month ago

Bio-Techne to Host Conference Call on February 5, 2025, to Announce Second Quarter Fiscal 2025 Financial Results

ScaleReady Announces a G-Rex® Grant has been awarded to BrainChild Bio

PR Newswire

a month ago

ScaleReady Announces a G-Rex® Grant has been awarded to BrainChild Bio

Is There Now An Opportunity In Bio-Techne Corporation (NASDAQ:TECH)?

Simply Wall St.

a month ago

Is There Now An Opportunity In Bio-Techne Corporation (NASDAQ:TECH)?

TECH Stock Might Rise From the Expansion of Designer Protein Portfolio

Zacks

a month ago

TECH Stock Might Rise From the Expansion of Designer Protein Portfolio

Bio-Techne Expands R&D Systems AI-Engineered Designer Protein Portfolio to Advance Cell Therapy and Regenerative Medicine

PR Newswire

a month ago

Bio-Techne Expands R&D Systems AI-Engineered Designer Protein Portfolio to Advance Cell Therapy and Regenerative Medicine

BIO-TECHNE TO PRESENT AT PHACILITATE ADVANCED THERAPIES WEEK 2025

PR Newswire

a month ago

BIO-TECHNE TO PRESENT AT PHACILITATE ADVANCED THERAPIES WEEK 2025

ScaleReady Announces a G-Rex® Grant has been awarded to Seattle Children's Therapeutics

PR Newswire

a month ago

ScaleReady Announces a G-Rex® Grant has been awarded to Seattle Children's Therapeutics

MT Newswires

a month ago

Bio-Techne Prevails in Second Reverse Engineering Claim by Miltenyi Biotec; Shares Up

BIO-TECHNE SUCCESSFUL ON SECOND CLAIM OF REVERSE ENGINEERING BY MILTENYI BIOTEC

PR Newswire

a month ago

BIO-TECHNE SUCCESSFUL ON SECOND CLAIM OF REVERSE ENGINEERING BY MILTENYI BIOTEC

Bio-Techne Inks New Agreement With Waters Corporation: Stock to Gain?

Zacks

2 months ago

Bio-Techne Inks New Agreement With Waters Corporation: Stock to Gain?

BIO-TECHNE TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

PR Newswire

2 months ago

BIO-TECHNE TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

MT Newswires

2 months ago

Bio-Techne, Waters Strike Co-Marketing, Co-Promotion Deal

BIO-TECHNE ANNOUNCES BIOTHERAPEUTIC CHARACTERIZATION STRATEGIC CO-MARKETING AND CO-PROMOTION AGREEMENT

PR Newswire

2 months ago

BIO-TECHNE ANNOUNCES BIOTHERAPEUTIC CHARACTERIZATION STRATEGIC CO-MARKETING AND CO-PROMOTION AGREEMENT

ScaleReady awards a G-Rex® Grant to Moonlight Bio

PR Newswire

2 months ago

ScaleReady awards a G-Rex® Grant to Moonlight Bio

MT Newswires

2 months ago

Bio-Techne Signs Distribution Deal With MedSanTek to Expand Product Reach in Turkey

Bio-Techne Launches ESR1 Mutation Monitoring Assay: Stock to Gain?

Zacks

2 months ago

Bio-Techne Launches ESR1 Mutation Monitoring Assay: Stock to Gain?

BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH MEDSANTEK TO EXPAND ACCESS TO PORTFOLIO ACROSS TURKEY

PR Newswire

2 months ago

BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH MEDSANTEK TO EXPAND ACCESS TO PORTFOLIO ACROSS TURKEY

BIO-TECHNE LAUNCHES ESR1 MUTATION MONITORING ASSAY

PR Newswire

2 months ago

BIO-TECHNE LAUNCHES ESR1 MUTATION MONITORING ASSAY

Morningstar Research

2 months ago

Analyst Report: Bio-Techne Corporation

Can Mixed Financials Have A Negative Impact on Bio-Techne Corporation's 's (NASDAQ:TECH) Current Price Momentum?

Simply Wall St.

3 months ago

Can Mixed Financials Have A Negative Impact on Bio-Techne Corporation's 's (NASDAQ:TECH) Current Price Momentum?

Should You Continue to Retain Bio-Techne Stock in Your Portfolio?

Zacks

3 months ago

Should You Continue to Retain Bio-Techne Stock in Your Portfolio?

Techne (TECH) Up 2.2% Since Last Earnings Report: Can It Continue?

Zacks

3 months ago

Techne (TECH) Up 2.2% Since Last Earnings Report: Can It Continue?

BIO-TECHNE TO PRESENT AT THE CITI 2024 GLOBAL HEALTHCARE CONFERENCE

PR Newswire

3 months ago

BIO-TECHNE TO PRESENT AT THE CITI 2024 GLOBAL HEALTHCARE CONFERENCE

MT Newswires

3 months ago

Bio-Techne's Select Fetal Bovine Serum Product Rights, Inventory Acquired by Gemini Bioproducts

Gemini Bioproducts, LLC Acquires Selected Fetal Bovine Serum (FBS) Product Rights and Inventory from Bio-Techne

PR Newswire

3 months ago

Gemini Bioproducts, LLC Acquires Selected Fetal Bovine Serum (FBS) Product Rights and Inventory from Bio-Techne

MT Newswires

3 months ago

Bio-Techne Signs Distribution Deal With Leader Life Sciences

BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH LEADER LIFE SCIENCES

PR Newswire

3 months ago

BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH LEADER LIFE SCIENCES

BIO-TECHNE AND ALZpath ANNOUNCE STRATEGIC PARTNERSHIP TO ADVANCE NEURODEGENERATIVE DISEASE RESEARCH

PR Newswire

3 months ago

BIO-TECHNE AND ALZpath ANNOUNCE STRATEGIC PARTNERSHIP TO ADVANCE NEURODEGENERATIVE DISEASE RESEARCH

Morningstar Research

3 months ago

Analyst Report: Bio-Techne Corporation

BIO-TECHNE TO HIGHLIGHT NOVEL SOLUTIONS FOR CANCER AND CARRIER SCREENING AT AMP 2024 ANNUAL MEETING & EXPO

PR Newswire

3 months ago

BIO-TECHNE TO HIGHLIGHT NOVEL SOLUTIONS FOR CANCER AND CARRIER SCREENING AT AMP 2024 ANNUAL MEETING & EXPO

UPDATED: BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS

PR Newswire

3 months ago

UPDATED: BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS

BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS

PR Newswire

3 months ago

BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS

BIO-TECHNE TO PRESENT AT INVESTOR CONFERENCES

PR Newswire

3 months ago

BIO-TECHNE TO PRESENT AT INVESTOR CONFERENCES

ScaleReady Announces multiple G-Rex® Grants have been awarded to leading investigators at the Baylor College of Medicine's Center for Cell and Gene Therapy

PR Newswire

3 months ago

ScaleReady Announces multiple G-Rex® Grants have been awarded to leading investigators at the Baylor College of Medicine's Center for Cell and Gene Therapy

Argus Research

3 months ago

Analyst Report: Bio-Techne Corp

Argus Research

3 months ago

Market Digest: CVX, EA, VIAV, REG, TECH, QSR, PLTR

There May Be Some Bright Spots In Bio-Techne's (NASDAQ:TECH) Earnings

Simply Wall St.

4 months ago

There May Be Some Bright Spots In Bio-Techne's (NASDAQ:TECH) Earnings

BIO-TECHNE TO PRESENT AT THE SOCIETY FOR IMMUNOTHERAPY OF CANCER (SITC) 39TH ANNUAL MEETING

PR Newswire

4 months ago

BIO-TECHNE TO PRESENT AT THE SOCIETY FOR IMMUNOTHERAPY OF CANCER (SITC) 39TH ANNUAL MEETING

Beyond the Balance Sheet: What SWOT Reveals About Bio-Techne Corp (TECH)

GuruFocus.com

4 months ago

Beyond the Balance Sheet: What SWOT Reveals About Bio-Techne Corp (TECH)

Morningstar Research

4 months ago

Analyst Report: Bio-Techne Corporation

LUNAPHORE COMET™ PLATFORM PAVES THE WAY FOR SPATIAL BIOLOGY ADOPTION IN CLINICAL RESEARCH

PR Newswire

4 months ago

LUNAPHORE COMET™ PLATFORM PAVES THE WAY FOR SPATIAL BIOLOGY ADOPTION IN CLINICAL RESEARCH

MT Newswires

4 months ago

Scotiabank Adjusts Bio-Techne's Price Target to $88 From $83

MT Newswires

4 months ago

Baird Adjusts Bio-Techne's Price Target to $84 From $82

MT Newswires

4 months ago

RBC Adjusts Bio-Techne's Price Target to $79 From $77

Morningstar Research

4 months ago

Analyst Report: Bio-Techne Corporation

Bio-Techne Corp (TECH) Q1 2025 Earnings Call Highlights: Navigating Growth and Challenges in a ...

GuruFocus.com

4 months ago

Bio-Techne Corp (TECH) Q1 2025 Earnings Call Highlights: Navigating Growth and Challenges in a ...

Thomson Reuters StreetEvents

4 months ago

Q1 2025 Bio-Techne Corp Earnings Call

Bio-Techne Tops Q1 Earnings & Revenue Estimates, Stock Up in Premarket

Zacks

4 months ago

Bio-Techne Tops Q1 Earnings & Revenue Estimates, Stock Up in Premarket

MT Newswires

4 months ago

Bio-Techne Fiscal Q1 Adjusted Earnings, Net Sales Rise

BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS

PR Newswire

4 months ago

BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS

BIO-TECHNE DECLARES DIVIDEND

PR Newswire

4 months ago

BIO-TECHNE DECLARES DIVIDEND

What to Expect From These 3 MedTech Stocks This Earnings Season

Zacks

4 months ago

What to Expect From These 3 MedTech Stocks This Earnings Season

ScaleReady Announces a G-Rex® Grant has been awarded to Luminary Therapeutics

PR Newswire

4 months ago

ScaleReady Announces a G-Rex® Grant has been awarded to Luminary Therapeutics

Bio-Techne Gears Up for Q1 Earnings Release: What's in the Cards?

Zacks

4 months ago

Bio-Techne Gears Up for Q1 Earnings Release: What's in the Cards?

Morningstar Research

4 months ago

Analyst Report: Bio-Techne Corporation

Calculating The Fair Value Of Bio-Techne Corporation (NASDAQ:TECH)

Simply Wall St.

4 months ago

Calculating The Fair Value Of Bio-Techne Corporation (NASDAQ:TECH)

BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 30, 2024, TO ANNOUNCE FIRST QUARTER FISCAL 2025 FINANCIAL RESULTS

PR Newswire

4 months ago

BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 30, 2024, TO ANNOUNCE FIRST QUARTER FISCAL 2025 FINANCIAL RESULTS

ScaleReady announces a G-Rex® Grant has been awarded to LIfT Biosciences

PR Newswire

4 months ago

ScaleReady announces a G-Rex® Grant has been awarded to LIfT Biosciences

Morningstar Research

4 months ago

Analyst Report: Bio-Techne Corporation

ScaleReady announces a G-Rex® Grant has been awarded to Dr. Eric Tran of the Earle A. Chiles Research Institute, a division of Providence Cancer Institute

PR Newswire

4 months ago

ScaleReady announces a G-Rex® Grant has been awarded to Dr. Eric Tran of the Earle A. Chiles Research Institute, a division of Providence Cancer Institute

ScaleReady announces a G-Rex® Grant has been awarded to renowned cancer immunologist Dr. Christopher A. Klebanoff

PR Newswire

5 months ago

ScaleReady announces a G-Rex® Grant has been awarded to renowned cancer immunologist Dr. Christopher A. Klebanoff

Argus Research

5 months ago

The Argus Mid-Cap Model Portfolio

LUNAPHORE PARTNERS WITH DISCOVERY LIFE SCIENCES TO BRING INNOVATIVE SPATIAL BIOLOGY SOLUTIONS TO CLINICAL RESEARCH

PR Newswire

5 months ago

LUNAPHORE PARTNERS WITH DISCOVERY LIFE SCIENCES TO BRING INNOVATIVE SPATIAL BIOLOGY SOLUTIONS TO CLINICAL RESEARCH

BIO-TECHNE TO PRESENT AT NEUROSCIENCE 2024-THE SOCIETY FOR NEUROSCIENCE (SfN) ANNUAL MEETING

PR Newswire

5 months ago

BIO-TECHNE TO PRESENT AT NEUROSCIENCE 2024-THE SOCIETY FOR NEUROSCIENCE (SfN) ANNUAL MEETING

Morningstar Research

5 months ago

Analyst Report: Bio-Techne Corporation

Bio-Techne (NASDAQ:TECH) stock performs better than its underlying earnings growth over last five years

Simply Wall St.

5 months ago

Bio-Techne (NASDAQ:TECH) stock performs better than its underlying earnings growth over last five years

BIO-TECHNE ISSUES 2024 CORPORATE SUSTAINABILITY REPORT

PR Newswire

5 months ago

BIO-TECHNE ISSUES 2024 CORPORATE SUSTAINABILITY REPORT

ScaleReady announces a G-Rex® Grant has been awarded to ImmunoScape

PR Newswire

5 months ago

ScaleReady announces a G-Rex® Grant has been awarded to ImmunoScape

ScaleReady announces a G-Rex® Grant has been awarded to Verismo Therapeutics

PR Newswire

5 months ago

ScaleReady announces a G-Rex® Grant has been awarded to Verismo Therapeutics

Verismo Therapeutics Awarded a ScaleReady™ G-Rex® Grant

PR Newswire

5 months ago

Verismo Therapeutics Awarded a ScaleReady™ G-Rex® Grant

ScaleReady and Bio-Techne Announce Optimal Closed System Cytokine Packaged for Single Step Use in Closed System G-Rex® Manufacture of CAR-T and TCR Therapies

PR Newswire

5 months ago

ScaleReady and Bio-Techne Announce Optimal Closed System Cytokine Packaged for Single Step Use in Closed System G-Rex® Manufacture of CAR-T and TCR Therapies

MT Newswires

5 months ago

RBC Raises Price Target on Bio-Techne to $77 From $70, Keeps Sector Perform Rating

Here’s What Dragged Bio-Techne Corporation (TECH)?

Insider Monkey

5 months ago

Here’s What Dragged Bio-Techne Corporation (TECH)?

Some May Be Optimistic About Bio-Techne's (NASDAQ:TECH) Earnings

Simply Wall St.

6 months ago

Some May Be Optimistic About Bio-Techne's (NASDAQ:TECH) Earnings

ScaleReady announces the inaugural G-Rex® Grant has been awarded to Stanford Medicine Laboratory for Cell and Gene Medicine

PR Newswire

6 months ago

ScaleReady announces the inaugural G-Rex® Grant has been awarded to Stanford Medicine Laboratory for Cell and Gene Medicine

BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES

PR Newswire

6 months ago

BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES

Bio-Techne Full Year 2024 Earnings: EPS Misses Expectations

Simply Wall St.

6 months ago

Bio-Techne Full Year 2024 Earnings: EPS Misses Expectations

Share on Social Networks: